MEK-ERK Pathway Modulation Ameliorates Disease Phenotypes in a Mouse Model of Noonan Syndrome Associated With the Raf1L613V Mutation
Journal of Clinical Investigation - United States
doi 10.1172/jci44929
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2011
Authors
Publisher
American Society for Clinical Investigation